Skip to main content
Caplight Logo









2bull MeDiTherapy

2bull MeDiTherapy

Private
GreeceHealthcare & Life Scienceshttps://2bullmeditherapy.com/

Last Round

Grant

Dec 2, 2022

Total Funding Raised

$1.09M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

2bull MeDiTherapy is a diagnostic equipment company that has developed TAP, a diagnostic blood test for detecting thoracic and abdominal aortic aneurysms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

molecular diagnosticsin-vitro diagnosticIVDaortic aneurysm screeningliquid biopsybiomarker testingRT-qPCRvascular disease diagnosticsnon-invasive diagnosticsprecision medicineblood-based testingmedical deviceclinical laboratory testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

2bull MeDiTherapy Comparables

Compare 2bull MeDiTherapy with similar companies based on industry and business-model similarity.

2bull MeDiTherapy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nectero Therapeutics
61%
Nurea
55%
ViTAA Medical Solutions
48%

2bull MeDiTherapy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 2, 2022
Pre SeedJan 10, 2019
AcceleratorJan 8, 2018

Key People

Founding team and executive leadership

Dimitris Kanistras

Chief Operating Officer

Executive Team

2bull MeDiTherapy Investors

Notable investors and investment history

2bull MeDiTherapy investors
InvestorRounds
egg - enter•grow•goAccelerator
Hellenic Republic Ministry of DevelopmentPre Seed
Elevate GreeceGrant
Big Pi VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 494% MoM, from 49 to 291.

  • May 2, 2025

    Monthly visitors grew 344% MoM, from 27 to 120.

2bull MeDiTherapy Filings

Explore SEC and related filing metadata, where available.

2bull MeDiTherapy filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about 2bull MeDiTherapy's valuation, stock price, and market status.

Is 2bull MeDiTherapy a public or private company?

2bull MeDiTherapy is a private company.

What is the current stock price of 2bull MeDiTherapy?

2bull MeDiTherapy is a private company with no public stock price. No recent secondary market data is available.

How much is 2bull MeDiTherapy worth (valuation)?

Valuation information for 2bull MeDiTherapy is not publicly available.

Can I buy 2bull MeDiTherapy stock?

2bull MeDiTherapy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was 2bull MeDiTherapy's last funding round?

2bull MeDiTherapy's most recent funding round was Grant on December 2, 2022.

Who are the main investors in 2bull MeDiTherapy?

Key investors in 2bull MeDiTherapy include Big Pi Ventures.

Will 2bull MeDiTherapy IPO soon?

No public IPO plans have been announced for 2bull MeDiTherapy.

How can I track 2bull MeDiTherapy secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 2bull MeDiTherapy's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGreece
Employee Range5
Year Founded2007
Last FundingDec 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?